INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapy
Haematologica
.
2022 Jun 1;107(6):1232-1234.
doi: 10.3324/haematol.2021.279549.
Author
Daniel Herranz
1
Affiliation
1
Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08901, USA; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ 08854. dh710@cinj.rutgers.edu.
PMID:
34647445
PMCID:
PMC9152966
DOI:
10.3324/haematol.2021.279549
No abstract available
Publication types
Comment
MeSH terms
Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
T-Lymphocytes